Internal Medicine, Cardiovascular Disease · Cincinnati, OH
NPI
1578530051
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
2123 Auburn Ave
Cincinnati, OH, 45219
Phone (513) 206-1120
Groups this clinician bills Medicare through
Medicare paid, 2024
$163K
3,658 services
Medicare patients, 2024
1,878
Average age 75
Drug cost, 2024
$5.9M
6,803 prescriptions
Company payments, 2025
$12K
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wojciech Mazur was code 99214 (office e&m - established), 806 times for 592 patients. In total Wojciech Mazur billed 3,658 services in 43 codes, and Medicare paid $163K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 806 | 592 | $86.32 | $70K |
| 93010 Electrocardiogram | Facility | 699 | 551 | $6.05 | $4,231 |
| 93000 Electrocardiogram | Office | 230 | 226 | $9.94 | $2,286 |
| 93306 Echocardiography (TTE/TEE) | Facility | 220 | 215 | $48.29 | $11K |
| 93306 Echocardiography (TTE/TEE) | Office | 178 | 176 | $47.23 | $8,407 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 168 | 125 | $12.46 | $2,093 |
| 93018 Electrocardiogram | Office | 110 | 110 | $10.33 | $1,136 |
| 99232 Hospital E&M - Subsequent | Facility | 108 | 66 | $57.29 | $6,188 |
| 78452 Myocardial Perfusion Scan | Office | 105 | 105 | $55.72 | $5,851 |
| 93325 Echocardiography (TTE/TEE) | Facility | 99 | 71 | $2.22 | $220 |
| 99215 Office E&M - Established | Office | 98 | 81 | $126.07 | $12K |
| 93308 Echocardiography (TTE/TEE) | Facility | 92 | 63 | $18.10 | $1,665 |
| 93321 Echocardiography (TTE/TEE) | Facility | 83 | 55 | $5.26 | $437 |
| 75561 MRI/MRA - Other | Facility | 69 | 68 | $90.20 | $6,223 |
| 99223 Hospital E&M - Initial | Facility | 49 | 48 | $124.40 | $6,095 |
By year: 2022 $154K for 3,763 services; 2023 $156K for 3,862 services; 2024 $163K for 3,658 services.
Medicare prescription drug claims, 2024
In 2024, the drug Wojciech Mazur prescribed most often to Medicare patients was Jardiance (Empagliflozin), with 573 prescriptions and refills. In total Wojciech Mazur wrote 6,803 Medicare prescriptions that cost $5.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jardiance Empagliflozin | 573 | 1,341 | 198 | $765K |
| Entresto Sacubitril/Valsartan | 492 | 1,114 | 146 | $684K |
| Ezetimibe Generic | 450 | 1,242 | 153 | $9,048 |
| Atorvastatin Calcium Generic | 449 | 1,285 | 150 | $3,979 |
| Eliquis Apixaban | 427 | 932 | 118 | $537K |
| Rosuvastatin Calcium Generic | 391 | 1,092 | 132 | $4,029 |
| Spironolactone Generic | 331 | 884 | 111 | $2,520 |
| Repatha Sureclick Evolocumab | 241 | 400 | 67 | $228K |
| Metoprolol Succinate Generic | 231 | 606 | 84 | $2,901 |
| Camzyos Mavacamten | 215 | 215 | 27 | $1.7M |
| Amlodipine Besylate Generic | 197 | 555 | 73 | $1,336 |
| Carvedilol Generic | 170 | 488 | 59 | $1,548 |
| Farxiga Dapagliflozin Propanediol | 158 | 370 | 49 | $204K |
| Xarelto Rivaroxaban | 153 | 313 | 40 | $171K |
| Clopidogrel Clopidogrel Bisulfate | 130 | 371 | 45 | $1,100 |
Brand drugs: - claims; generic drugs: 3,953 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wojciech Mazur $12K ($12K in general payments such as food, travel and fees) from 4 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $12K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.